Greenwich, CTCIK 10126224 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
17 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Genedx Holdings Corp | 884.7K | $115.06M | 75.4% | −5.3K | Reduced |
| 2 | Ardelyx Inc | 1.87M | $10.92M | 7.2% | +368.8K | Added |
| 3 | Biohaven Ltd | 772.2K | $8.72M | 5.7% | +32.2K | Added |
| 4 | Quidelortho Corp |
| 118.3K |
| $3.38M |
| 2.2% |
| 0 |
| Held |
| 5 | Forian Inc | 1.37M | $2.90M | 1.9% | 0 | Held |
| 6 | Personalis Inc | 339.3K | $2.70M | 1.8% | +109.9K | Added |
| 7 | Teladoc Health Inc | 354.3K | $2.48M | 1.6% | −351.1K | Reduced |
| 8 | Taysha Gene Therapies Inc | 265.0K | $1.46M | 1.0% | +265.0K | New |
| 9 | Cava Group Inc | 17.1K | $1.00M | 0.7% | 0 | Held |
| 10 | Edgewise Therapeutics Inc | 38.3K | $951.5K | 0.6% | +38.3K | New |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio